Drilldown: Medicines
Use the filters below to narrow your results.
generic:
Amantadine (1) ·
Amobarbital (1) ·
Apomorphine (1) ·
Asenapine (1) ·
Benztropine (1) ·
Biperiden (1) ·
Bromocriptine (1) ·
Butalbital (1) ·
Cabergoline (1) ·
Carbidopa/levodopa (1) ·
Chlorpromazine (1) ·
Clozapine (1) ·
Droperidol (1) ·
Entacapone (1) ·
Fluphenazine (1) ·
Iloperidone (1) ·
Levodopa (1) ·
Loxapine (1) ·
Lurasidone (1) ·
Methohexital (1) ·
Molindone (1) ·
Opicapone (1) ·
Paliperidone (1) ·
Pentobarbital (1) ·
Perphenazine (1) ·
Phenobarbital (1) ·
Pimozide (1) ·
Rasagiline (1) ·
Rotigotine (1) ·
Safinamide (1) ·
Secobarbital (1) ·
Selegiline (1) ·
Thiopental (1) ·
Thioridazine (1) ·
Thiothixene (1) ·
Tolcapone (1) ·
Trifluoperazine (1) ·
Trihexyphenidyl (1) ·
Ziprasidone (1)
brand:
None (2) ·
Akineton (1) ·
Amytal (1) ·
Apokyn (1) ·
Artane (1) ·
Azilect (1) ·
Brevital (1) ·
Clozaril (1) ·
Cogentin (1) ·
Comtan (1) ·
Dostinex (1) ·
Eldepryl (1) ·
Fanapt (1) ·
Geodon (1) ·
Inapsine (1) ·
Invega (1) ·
Latuda (1) ·
Loxitane (1) ·
Luminal (1) ·
Mellaril (1) ·
Moban (1) ·
Navane (1) ·
Nembutal (1) ·
Neupro (1) ·
Ongentys (1) ·
Orap (1) ·
Parlodel (1) ·
Pentothal (1) ·
Prolixin (1) ·
Saphris (1) ·
Seconal (1) ·
Sinemet (1) ·
Stelazine (1) ·
Symmetrel (1) ·
Tasmar (1) ·
Thorazine (1) ·
Trilafon (1) ·
Xadago (1)
classes: (Click arrow to add another value)
mechanism:
None (2) ·
Butyrophenone D2 antagonist (1) ·
Central and peripheral COMT inhibitor (1) ·
D1/D2/D3 receptor agonist (1) ·
D2 agonist; D1 partial agonist (1) ·
D2 receptor agonist (1) ·
D2 receptor antagonist; also H1, alpha-1, muscarinic antagonist (1) ·
D2/5-HT2A antagonist (1) ·
D2/5-HT2A antagonist; 5-HT7 antagonist (1) ·
D2/5-HT2A antagonist; active metabolite of risperidone (1) ·
D2/5-HT2A antagonist; SRI and NRI (1) ·
Dibenzoxazepine D2/5-HT2 antagonist (1) ·
Dihydroindolone D2 antagonist (1) ·
Diphenylbutylpiperidine D2 antagonist (1) ·
Dopamine precursor (1) ·
Dopamine precursor + DOPA decarboxylase inhibitor (1) ·
GABAA potentiator and direct activator (3) ·
GABAA potentiator; ultra-short-acting (2) ·
Irreversible selective MAO-B inhibitor (2) ·
MAO-B inhibitor; sodium channel blocker; glutamate release inhibitor (1) ·
Multi-receptor antagonist (D2, 5-HT2A, H1, alpha) (1) ·
Multi-receptor antagonist; low D2 affinity (1) ·
Muscarinic receptor antagonist (1) ·
Muscarinic receptor antagonist; dopamine reuptake inhibitor (1) ·
NMDA antagonist; dopamine releasing agent (1) ·
Non-selective dopamine receptor agonist (1) ·
Once-daily COMT inhibitor (1) ·
Peripheral COMT inhibitor (1) ·
Phenothiazine D2 antagonist (4) ·
Selective M1 muscarinic antagonist (1) ·
Thioxanthene D2 antagonist (1)
uses:
starting dose:
preparations:
fda max:
routes:
onset:
duration:
halflife:
bioavailability:
pregnancy:
legal:
Showing below up to 39 results in range #1 to #39.